Overview
Description
Percheron Therapeutics Ltd. is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions. The company operates within the broader pharmaceutical sector, targeting unmet medical needs and rare disease conditions with novel treatment options. Percheron Therapeutics Ltd. leverages advanced biotechnological research and proprietary development platforms to create therapies that have the potential to transform patient care. Through strategic collaborations and partnerships, the company enhances its research capabilities and accelerates its product development process. In the financial market, Percheron Therapeutics Ltd. plays a significant role as an emerging player in biotech innovation, contributing to advancements in medicine and offering potential growth opportunities for stakeholders engaged in the healthcare ecosystem. Its focus on specialized therapies underscores its commitment to addressing complex conditions that traditional treatment modalities have yet to solve.
About
CEO
Dr. James Garner B.Sc (Hons), B.Sc., M.A., M.A.I.C.D., M.B.A., MBA
Employees
0
Address
L30, Collins Place
35 Collins Street
Melbourne, 3000, VIC
Australia
35 Collins Street
Melbourne, 3000, VIC
Australia
Phone
61 3 9827 8999
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Australia
MIC code
XASX